<?xml version="1.0" encoding="UTF-8"?>
<p id="p0201" num="0201" sourceFile="EP 1326865B1.xml">The title compound was prepared using the procedure described in Example 2, Step 2 replacing 2,5 dichlorobenzylamine with 1-(2,3-dihydro-1H-inden-1-yl)methanamine.
  <br/>
  <sup>1</sup>H NMR (d
  <sub>6</sub>DMSO, 400MHz) δ 9.42 (1H, m), 9.17 (1H, d, 
  <i>J</i>=4.1 Hz), 8.92 (1H, s), 8.61 (1H, d, 
  <i>J</i>=8.3Hz), 7.84 (1H, dd, 
  <i>J</i>=8.3 and 4.1 Hz), 7.40-7.10 (4H, m), 3.80-3.30 (3H,m), 3.05-2.70 (2H, m), 2.30-2.10 (1H, m) and 2.00-1.80 (1H, m) ppm.
  <br/> FAB MS calcd for C
  <sub>19</sub>H
  <sub>17</sub>N
  <sub>3</sub>O
  <sub>2</sub> 320(MH
  <sup>+</sup>), found 320.
  <br/> FAB HRMS exact mass calcd for C
  <sub>19</sub>H
  <sub>17</sub>N
  <sub>3</sub>O
  <sub>2</sub> 320.1394 (MH
  <sup>+</sup>), found 320.1393.
</p>
